AMY SOBAS: Open Payments
NPI 1205872132 · PORTAGE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 44 payments from 12 companies in 2025. Trend: 2023 $977 · 2024 $942 · 2025 $817
Food & beverage: $817
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $161 |
| Novo Nordisk Inc | 9 | $158 |
| PFIZER INC. | 6 | $98 |
| Lilly USA, LLC | 4 | $76 |
| ABBVIE INC. | 4 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $44 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
Products named: NURTEC ODT, BREZTRI, FARXIGA, Wegovy, MOUNJARO, REXULTI, Auvelity, Kerendia.
Industry payments across IN — which companies pay providers there.
